8-K: ZIVO Board Member Resigns, No Disagreement Cited

ZIVO Bioscience announces the immediate resignation of Board Director Nola Masterson, who chaired the Nominating and Governance committee.

Summary

• Ms. Nola Masterson resigned from ZIVO Bioscience, Inc.'s Board of Directors, effective August 12, 2025.
• Her resignation was explicitly stated not to be a result of any disagreement with the company's operations, policies, or practices.
• Ms. Masterson served as chair of the Nominating and Governance committee and was a member of both the Audit and Compensation committees.
• The Board of Directors has not yet named a replacement to fill the open board seat.

Sentiment

Score: 5

Explanation: The resignation of a board member, especially one holding key committee roles, is generally a neutral to slightly negative event. However, the explicit statement that the resignation was not due to disagreements prevents a more negative sentiment, placing it in a neutral 'expected' category.

Positives

• The resignation was explicitly stated not to be a result of any disagreement with the company's operations, policies, or practices, indicating no underlying conflict.

Negatives

• The company has an open board seat with no immediate replacement named, potentially impacting governance and committee functions.
• The departure of a director who chaired a key committee (Nominating and Governance) and served on two others (Audit and Compensation) creates a void in experienced oversight.

Risks

• A vacant board seat, especially one previously held by a chair of the Nominating and Governance committee and member of Audit and Compensation committees, could lead to temporary governance inefficiencies or increased workload for remaining directors.
• Delay in appointing a qualified replacement could raise concerns about board stability and strategic direction.

Management Comments

• The Board of Directors and the Company thank Ms. Masterson for her service and contributions to the Company and the Board of Directors during her tenure.

Industry Context

Board resignations are a common occurrence in publicly traded companies, often due to personal reasons or new opportunities. The explicit statement that the resignation was not due to disagreements with company operations or policies is a positive signal, differentiating it from resignations that might indicate internal strife or strategic misalignment, which can be more concerning to investors.

Management Changes

Corporate Governance

Stakeholder Impact

• Shareholders may experience minor uncertainty due to a vacant board seat and the need for a new director, but the lack of disagreement mitigates significant concern.
• Management will need to work with the remaining board members to identify and appoint a suitable replacement, potentially increasing workload for existing directors.

Next Steps

• The Board of Directors needs to name a replacement to fill the open board seat.

Key Dates

Recommendation

The filing reports a routine board resignation without any stated disagreements, which is a neutral event. While the vacancy on key committees needs to be addressed, there is no immediate indication of operational or financial distress. Therefore, a 'hold' recommendation is appropriate as this event alone does not warrant a change in investment thesis.

Keywords

ZIVO Bioscience, Board of Directors, Resignation, Corporate Governance, SEC Filing, 8-K, Nominating and Governance Committee, Audit Committee, Compensation Committee